Sucampo Pharmaceuticals 10K 2014 Annual report | SEC Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: actuarial, Addendum, Alder, alerted, amenable, AMITIA, AMITZA, ANDA, answer, API, appointed, appraisal, ASC, Astra, atrophic, atrophy, Austria, aware, Barring, begun, belief, benchmark, billion, binocular, breakthrough, broadest, Brownian, built, Caff, certainty, classification, cliff, compatibility, complaint, concept, constitute, contact, core, counter, counterclaim, cyclase, cycle, deep, Degradation, depressing, depth, developmental, die, differentiated, dilated, distinct, distraction, diversification, diversified, diversify, diversifying, double, dual, endoscopic, enjoining, enrich, epithelium, erosive, eventual, excessive, exit, FACP, fed, fiduciary, flagship, flexibility, footnote, fourteenth, fovea, FTC, gastro, Geometric, GERD, GmbH, guanylyl, harnessing, heartburn, inability, indemnitee, inherited, injunction, injunctive, instance, intercellular, Ireland, Italy, Jersey, John, Kiener, leveraging, likelihood, macroscopic, macroscopically, median, Microscopically, mid, monocular, mutant, myelotoxic, Mylan, NERD, occasion, occurrence, omission, outweigh, Paragraph, passion, passionate, patentee, pension, photoreceptor, pigment, pilot, Plant, PMPRB, PPI, preliminary, prioritized, proceeding, proof, proportionality, proposition, proton, protracted, pump, pursuit, put, Quantifying, reappointment, Reddy, reflux, refractory, regional, reoccur, rescind, resubmitted, resume, retrospective, Robert, RPE, run, salary, sensory, setback, sight, sizable, skipped, solid, Spain, Spiegel, spread, standalone, stayed, Steven, stipulation, strongest, Subpart, subtype, swallowing, Sweden, therewith, track, transformation, transformative, troublesome, uncover, undergone, unenforceable, unfunded, unpredictable, unwavering, viability, virtue, vital, vitro, voluntarily, weekly, wide, widely, Zeneca

Removed: abandonment, absorption, academic, advisor, affirm, aging, alleged, Alto, analog, anticipation, arranged, assign, assimilation, Assistant, attainment, Australia, baseline, beneficially, beta, biofuel, Boeing, borne, Burlington, California, Cardiology, cardiovascular, CEO, CFO, Chicago, clarified, Columbia, commencing, comparing, complementary, Constellation, consultant, convert, COR, Counsel, CRO, culminating, cured, customary, Dayton, denied, Depot, Deputy, description, distension, diversion, docosanoid, economically, education, elevated, Energy, engineering, Enterprise, evolving, Exemplar, expended, expressly, Fe, formally, Fort, founder, GE, Generation, geographical, gradually, graduated, grow, Hg, Home, hospital, humor, impede, implementing, improper, inception, incurrence, IND, informed, inhibited, instrument, integrate, intense, irreversible, ischemic, joining, Keio, latanaprost, Loyola, maleate, MBA, MCI, Merck, meshwork, methylaltrexone, mild, Millennium, mm, nausea, necessitate, NorthWestern, OAG, observed, ophthalmology, outflow, overstating, Palo, Park, Paul, permission, Pfizer, POAG, predecessor, predominantly, President, progressively, promoted, prostaglandin, publicly, pulmonary, quantity, quickly, Railway, reauthorization, recoverability, recovered, Relistor, relocating, remained, renew, requirement, resource, rolling, safer, sample, Santa, satisfaction, scale, School, scoring, Seattle, Secretary, selected, senior, served, serving, shared, SPA, SPE, SPL, statistically, strong, subcontractor, substance, successive, supplementation, supplemented, survival, swelling, Syntex, systemic, tafluprost, terminable, thereof, TIBOR, tiered, topographic, trabecular, transient, understating, University, unwilling, Vice, Villanova, Worth, Zealand

Date: March 9, 2015	/s/ PETER GREENLEAF
	Peter Greenleaf
	Chief Executive Officer
	(Principal Executive Officer)

Sucampo Pharmaceuticals Inactive 10-K2014 FY Annual report

Content analysis